TPI levels and rheumatoid arthritis activity
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at a protein called TPI in the blood of people with rheumatoid arthritis (RA). It aims to see if TPI levels are linked to how active the disease is and whether it causes joint damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 years or older).
- You must have a diagnosis of rheumatoid arthritis (RA).
- You must not have other serious chronic conditions like uncontrolled high blood pressure, diabetes, heart disease, liver or kidney disease, other autoimmune diseases, or cancer.
- You must not be pregnant.
- You must not have other rheumatic diseases besides RA.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a new blood test that might help doctors diagnose rheumatoid arthritis, especially for people who don't have the usual markers in their blood. It could help more people get the right diagnosis earlier.
This study is testing whether a simple blood test can help predict how well patients respond to anti-TNF alpha treatments (like Humira or Enbrel) for rheumatoid arthritis. If successful, this could help doctors choose the right medication sooner, saving you time and improving your quality of life.
This study looks at new ways to detect lung problems that can happen with rheumatoid arthritis. By finding these issues earlier, doctors may be able to treat them better and improve your quality of life.
This study looks at whether mild thyroid problems, called subclinical hypothyroidism, are linked to more active rheumatoid arthritis. If you have rheumatoid arthritis, your thyroid function will be checked to see if it affects your joint symptoms.
This study tests a new oral medication, PTC844, for people with active rheumatoid arthritis whose current treatments have not worked well enough or who haven't tried any yet. The goal is to see if it can reduce joint pain and swelling.
This study looks at whether a protein called isthmin-1 in your blood can show how active your rheumatoid arthritis is. It compares this protein level with ultrasound images of your joints to see if it could help monitor the disease.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.